Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 12


Impact of a decade of successful antiretroviral therapy initiated at HIV-1 seroconversion on blood and rectal reservoirs.

Malatinkova E, Spiegelaere WD, Bonczkowski P, Kiselinova M, Vervisch K, Trypsteen W, Johnson M, Verhofstede C, Looze Dd, Murray C, Loes SK, Vandekerckhove L.

Elife. 2015 Oct 6;4. pii: e09115. doi: 10.7554/eLife.09115.


How does the timing of antiretroviral therapy initiation in acute infection affect HIV reservoirs?

Ananworanich J, Dubé K, Chomont N.

Curr Opin HIV AIDS. 2015 Jan;10(1):18-28. doi: 10.1097/COH.0000000000000122. Review.


Can early therapy reduce inflammation?

Sandler NG, Sereti I.

Curr Opin HIV AIDS. 2014 Jan;9(1):72-9. doi: 10.1097/COH.0000000000000020. Review.


The detection and management of early HIV infection: a clinical and public health emergency.

Smith MK, Rutstein SE, Powers KA, Fidler S, Miller WC, Eron JJ Jr, Cohen MS.

J Acquir Immune Defic Syndr. 2013 Jul;63 Suppl 2:S187-99. doi: 10.1097/QAI.0b013e31829871e0. Review.


Cell-associated HIV RNA: a dynamic biomarker of viral persistence.

Pasternak AO, Lukashov VV, Berkhout B.

Retrovirology. 2013 Apr 15;10:41. doi: 10.1186/1742-4690-10-41. Review.


Similar evolution of cellular HIV-1 DNA level in darunavir/ritonavir monotherapy versus triple therapy in MONOI-ANRS136 trial over 96 weeks.

Lambert-Niclot S, Flandre P, Valantin MA, Soulie C, Fourati S, Wirden M, Sayon S, Pakianather S, Bocket L, Masquelier B, Dos Santos G, Katlama C, Calvez V, Marcelin AG.

PLoS One. 2012;7(7):e41390. doi: 10.1371/journal.pone.0041390. Epub 2012 Jul 25.


Should we treat acute HIV infection?

O'Brien M, Markowitz M.

Curr HIV/AIDS Rep. 2012 Jun;9(2):101-10. doi: 10.1007/s11904-012-0113-0. Review.


Efficacy of NNRTI-based antiretroviral therapy initiated during acute HIV infection.

Gay CL, Mayo AJ, Mfalila CK, Chu H, Barry AC, Kuruc JD, McGee KS, Kerkau M, Sebastian J, Fiscus SA, Margolis DM, Hicks CB, Ferrari G, Eron JJ; Duke-UNC Acute HIV Infection Consortium.

AIDS. 2011 Apr 24;25(7):941-9. doi: 10.1097/QAD.0b013e3283463c07.


Early and prolonged antiretroviral therapy is associated with an HIV-1-specific T-cell profile comparable to that of long-term non-progressors.

Cellerai C, Harari A, Stauss H, Yerly S, Geretti AM, Carroll A, Yee T, Ainsworth J, Williams I, Sweeney J, Freedman A, Johnson M, Pantaleo G, Kinloch-de Loes S.

PLoS One. 2011 Apr 5;6(4):e18164. doi: 10.1371/journal.pone.0018164.


The virologic and immunologic effects of cyclosporine as an adjunct to antiretroviral therapy in patients treated during acute and early HIV-1 infection.

Markowitz M, Vaida F, Hare CB, Boden D, Mohri H, Hecht FM, Kalayjian RC, Conrad A, Mildvan D, Aberg J, Hogan C, Kilby JM, Balfour HH Jr, Schafer K, Richman D, Little S.

J Infect Dis. 2010 May 1;201(9):1298-302. doi: 10.1086/651664.


Antiretroviral therapy in acute and recent HIV infection: a prospective multicenter stratified trial of intentionally interrupted treatment.

Volberding P, Demeter L, Bosch RJ, Aga E, Pettinelli C, Hirsch M, Vogler M, Martinez A, Little S, Connick E; ACTG 371 Team.

AIDS. 2009 Sep 24;23(15):1987-95. doi: 10.1097/QAD.0b013e32832eb285.


Development and assessment of a multiplex real-time PCR assay for quantification of human immunodeficiency virus type 1 DNA.

Beloukas A, Paraskevis D, Haida C, Sypsa V, Hatzakis A.

J Clin Microbiol. 2009 Jul;47(7):2194-9. doi: 10.1128/JCM.01264-08. Epub 2009 May 6.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk